This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Harmala alkaloid: Difference between revisions
>Astrid m →Chemistry: Added space between "of" and "beta-carboline". |
>Namesicny m Changed effect "Creativity" to creativity enhancement so it could be clicked on. |
||
| (24 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
'''Harmala alkaloids''' are a group of psychoactive alkaloids found primarily within the seeds of [[Harmala_alkaloid#Peganum_harmala_.28syrian_rue.29|'' | '''Harmala alkaloids''' are a group of psychoactive alkaloids found primarily within the seeds of [[Harmala_alkaloid#Peganum_harmala_.28syrian_rue.29|''Peganum harmala'']], also known as syrian rue. These alkaloids are of interest for their use in Amazonian shamanism, where they are derived from plants. Harmala alkaloids are naturally occurring beta-carboline alkaloids that are structurally related to harmaline, and also found in the vine [[Banisteriopsis caapi]]. They also occur in [[tobacco]], and contribute to its subjective effects, but not to its addictiveness (which is instead caused by the presence of nicotine), and in more negligible amounts than in Peganum Harmala and Banisteriopsis cappi. | ||
==Chemistry== | ==Chemistry== | ||
| Line 5: | Line 5: | ||
==Pharmacology== | ==Pharmacology== | ||
Harmala alkaloids are classed as [[MAOIs]]. This means that they inhibit the activity of monoamine oxidase metabolic enzymes of which two varieties exist: MAO-A and MAO-B. The [[alkaloids]] bind reversibly to the active site of the enzyme, inhibiting its endogenous function of destroying amine functions of [[neurotransmitters]] and externally administered centrally active drugs. This has the effect of potentiating and prolonging the central and peripheral activity of both neurotransmitters and a variety of drugs. They are reversible [[MAOIs]] of the MAO-A isoform of the enzyme, and can stimulate the central nervous system by inhibiting the metabolism of monoamine compounds such as serotonin and norepinephrine. | Harmala alkaloids are classed as [[MAOIs]]. This means that they inhibit the activity of monoamine oxidase metabolic enzymes, of which two varieties exist: MAO-A and MAO-B. The [[alkaloids]] bind reversibly to the active site of the enzyme, inhibiting its endogenous function of destroying amine functions of [[neurotransmitters]] and externally administered centrally active drugs. This has the effect of potentiating and prolonging the central and peripheral activity of both neurotransmitters and a variety of drugs. They are reversible [[MAOIs]] of the MAO-A isoform of the enzyme, and can stimulate the central nervous system by inhibiting the metabolism of monoamine compounds such as serotonin and norepinephrine. | ||
Harmala alkaloids are selective for MAO-A at reasonable doses and bind to the enzyme temporarily, so they are classed as a [[RIMA|reversible inhibitor of monoamine-A]] ([[RIMA]]). At higher doses, they also | Harmala alkaloids are selective for MAO-A at reasonable doses and bind to the enzyme temporarily, so they are classed as a [[RIMA|reversible inhibitor of monoamine-A]] ([[RIMA]]). At higher doses, they also affect the MAO-B enzyme. Because of the reversible selectivity for MAO-A, harmala alkaloids are considered to be less dangerous when combined with food containing [[tyramine]] and other substances with monoamine moieties which are reliant on monoamine oxidase for decomposition. | ||
However, it is important to understand that this does not imply that harmala alkaloids will not cause neurotoxicity. Harmala alkaloids temporarily disable the brain's primary mechanism for breaking down [[neurotransmitters]] and drugs which can have negative consequences as material builds up in the [[synapses]], leading to a huge range of downstream central and peripheral effects including [[sedation]], [[stimulation]], [[anxiety]], [[cognitive dysphoria]], [[Physical euphoria|euphoria]], [[headaches]], [[eye strain]], and [[muscle convulsions]]. The harmala alkaloids are not especially [[Psychedelics|psychedelic]], even at higher dosages, when hypnagogic visions, alongside [[vomiting]] and [[diarrhea]], become the main effect. | However, it is important to understand that this does not imply that harmala alkaloids will not cause neurotoxicity. Harmala alkaloids temporarily disable the brain's primary mechanism for breaking down [[neurotransmitters]] and drugs which can have negative consequences as material builds up in the [[synapses]], leading to a huge range of downstream central and peripheral effects including [[sedation]], [[stimulation]], [[anxiety]], [[cognitive dysphoria]], [[Physical euphoria|euphoria]], [[headaches]], [[eye strain]], and [[muscle convulsions]]. The harmala alkaloids are not especially [[Psychedelics|psychedelic]], even at higher dosages, when hypnagogic visions, alongside [[vomiting]] and [[diarrhea]], become the main effect. | ||
| Line 17: | Line 17: | ||
==Examples== | ==Examples== | ||
Common harmala alkaloids include: | Common harmala alkaloids include: | ||
====Harmane==== | |||
[[File:Harmane_structure.svg|278px]] | |||
'''Harmane''' ('''harman''') is a MAO-A inhibitor.<ref name="pmid35832393">https://www.frontiersin.org/articles/10.3389/fnmol.2022.925272/full</ref><ref name="harman">{{cite journal |last1=Herraiz |first1=T |last2=Chaparro |first2=C |title=Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee. |journal=Life sciences |date=18 January 2006 |volume=78 |issue=8 |pages=795-802 |doi=10.1016/j.lfs.2005.05.074 |pmid=16139309}}</ref><!-- Added to: MAOI, Harmala alkaloid --> | |||
====Harmine==== | ====Harmine==== | ||
| Line 43: | Line 48: | ||
'''L-Tetrahydroharmine''' does not inhibit monoamine oxidase A. Instead, it weakly [[Reuptake inhibitor|inhibits reuptake]] of [[serotonin]]. | '''L-Tetrahydroharmine''' does not inhibit monoamine oxidase A. Instead, it weakly [[Reuptake inhibitor|inhibits reuptake]] of [[serotonin]]. | ||
'''D-THH''', on the other hand, has similar potency in terms of inhibiting MAO as harmine. | '''D-THH''', on the other hand, has similar potency in terms of inhibiting MAO as harmine. | ||
==Subjective effects== | ==Subjective effects== | ||
| Line 80: | Line 85: | ||
*'''[[Effect::Dream potentiation]]''' | *'''[[Effect::Dream potentiation]]''' | ||
*'''[[Effect::Time distortion]]''' | *'''[[Effect::Time distortion]]''' | ||
*'''[[Effect::Creativity]]''' | *'''[[Effect::Creativity enhancement]]''' | ||
*'''[[Effect::Conceptual thinking]]''' | *'''[[Effect::Conceptual thinking]]''' | ||